# OnCo record socazolimab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/socazolimab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "socazolimab" ;
  schema:name "Socazolimab"@en ;
  schema:description "Socazolimab is Lee's Pharmaceutical's PD-L1 antibody, in phase 3 trials in China for extensive-stage small cell lung cancer and recurrent cervical cancer."@en ;
  schema:url <https://onco.cc/drugs/socazolimab/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=ZKAB001> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Anti-PD-L1 monoclonal antibody, intravenous" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/sclc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pdl1/> ;
  onco:companies <https://onco.cc/companies/lees-pharmaceutical/> ;
  onco:trials <https://onco.cc/trials/nct06459687/> .
